(Q35127938)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Pierre-Jean Lamy

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Muriel Mathonnet

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Marc Ychou

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Caroline Bascoul-Mollevi

4

object named as

Caroline Mollevi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Alain R Thierry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Safia El Messaoudi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Evelyne Lopez-Crapez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Fanny Rolet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Brigitte Gillet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Celine Gongora

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Pierre Dechelotte

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Bruno Robert

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Maguy Del Rio

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Frederic Bibeau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Michelle Nouaille

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Virginie Loriot

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Anne-Sophie Jarrousse

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Franck Molina

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Denis Pezet

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

language of work or name

English

0 references

publication date

23 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

430-435

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24658074%20AND%20SRC:MED&resulttype=core&format=json

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer

11 March 2020

cites work

1 reference

12 December 2020

Isolation and characterization of DNA from the plasma of cancer patients

1 reference

12 December 2020

Cell-free nucleic acids as biomarkers in cancer patients

1 reference

12 December 2020

Circulating mutant DNA to assess tumor dynamics

1 reference

12 December 2020

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens

1 reference

12 December 2020

A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.

1 reference

12 December 2020

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

1 reference

12 December 2020

Colorectal cancer molecular biology moves into clinical practice

1 reference

12 December 2020

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

12 December 2020

Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan.

1 reference

12 December 2020

Circulating tumour markers can define patients with normal colons, benign polyps, and cancers

1 reference

12 December 2020

Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts

1 reference

12 December 2020

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

1 reference

12 December 2020

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

1 reference

12 December 2020

Circulating cell free DNA: Preanalytical considerations

1 reference

12 December 2020

Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients

1 reference

12 December 2020

Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer.

1 reference

12 December 2020

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

1 reference

12 December 2020

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

1 reference

12 December 2020

Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy

1 reference

12 December 2020

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

12 December 2020

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients

1 reference

12 December 2020

The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR.

1 reference

12 December 2020

Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer.

1 reference

12 December 2020

Development of personalized tumor biomarkers using massively parallel sequencing

1 reference

12 December 2020

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

1 reference

12 December 2020

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

1 reference

12 December 2020

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

1 reference

12 December 2020

KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology

1 reference

12 December 2020

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

1 reference

12 December 2020

KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues

1 reference

12 December 2020

KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab

1 reference

12 December 2020

Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases

1 reference

12 December 2020

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

12 December 2020

The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients.

1 reference

12 December 2020

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

1 reference

12 December 2020

KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment

1 reference

12 December 2020

High fragmentation characterizes tumour-derived circulating DNA.

1 reference

12 December 2020

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

12 December 2020

Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer

1 reference

12 December 2020